OpGen Inc (LTS:0A8L)
$ 5.087 0 (0%) Market Cap: 4.87 Mil Enterprise Value: 17.13 Mil PE Ratio: 0 PB Ratio: 1.72 GF Score: 34/100

Q1 2021 OpGen Inc Earnings Call Transcript

May 13, 2021 / 12:30PM GMT
Release Date Price: $404 (-14.70%)
Operator

Good morning, and thank you for joining us today. I would now like to hand the call over to Megan Paul of Investor Relations. Megan, the floor is yours.

Megan Paul
Edison Group - Senior Associate of IR

Welcome to the OpGen First Quarter 2021 Earnings Call and Business Update. At this time, all participants are in a listen-only mode. Following management's prepared remarks, there will be a Q&A session. As a reminder, this conference call is being recorded today, May 13, 2021.

Before we begin, I would like to caution you that comments made during this conference call by management may contain forward-looking statements regarding the operations of and future results of OpGen, including its subsidiaries Curetis and Ares Genetics. We encourage you to review OpGen's filings with the Securities and Exchange Commission, including without limitation the company's most recent Form 10-K and Form 10-Q for the first quarter of 2021, that may be filed with the SEC -- that will be filed with the SEC, which will identify specific factors that may cause actual

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot